← SynDRA

liraglutide

SynDRA canonical compound SYN0041877 — structure-anchored drug synonym record

All known targets

• GLP1R
• GCG
• INS

Mechanisms of action (all sources)

• GLP1R AGONIST
• Glucagon-like peptide 1 receptor agonist
• GLP1R FULL AGONIST
• GLP receptor agonist

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

• ALB
• HDAC6

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

• ECE1
• MUS81

Drug classes

• Glucagon-like Peptide-1 (GLP-1) Agonists
• Hormones
• Hypoglycemic Agents
• Incretins
• GLP-1 Receptor Agonist
• Glucagon-Like Peptide-1 Receptor Agonists

ATC classes

• A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
• INSULINS AND ANALOGUES

Cross-references

• PubChem CID: 16134956
• ChEMBL: CHEMBL4084119
• DrugBank: DB06655
• ChEBI: CHEBI:71193
• KEGG: D06404
• RxNorm: 475968
• Wikipedia: Liraglutide
• TTD: D03GOI

Synonyms

• SAXENDA
• Saxenda
• VICTOZA
• Victoza
• saxenda
• liraglutide [rDNA origin]
• liraglutide rDNA origin
• liraglutide [rNDA origin] injection
• NN2211
• victoza
• liraglutide recombinant
• Liraglutide recombinant
• Liraglutida
• Liraglutide (rdna origin)
• NN-2211
• NN-9924
• NN9924
• NNC-90-1170
• Liraglutide component of xultophy 100/3.6
• Liraglutidum
• Liraglutida [INN-Spanish]
• Liraglutide [USAN:INN]
• Liraglutidum [INN-Latin]
• Victoza (TN)
• N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide
• N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide
• XULTOPHY 100/3.6 COMPONENT LIRAGLUTIDE
• Liraglutide (genetical recombination)
• NN 2211
• Liraglutide (rDNA origin)
• CHEBI:71193
• RefChem:5950
• A10BJ02
• DTXCID701508545
• Liraglutide?
• UNII-839I73S42A
• HSDB 8205